Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mai P Hoang, M.D.

Co-Author

This page shows the publications co-authored by Mai Hoang and Meera Mahalingam.
Connection Strength

4.471
  1. Porocarcinoma: an exceedingly rare tumor or a tumor eclipse phenomenon?--Reply. Hum Pathol. 2013 Mar; 44(3):449.
    View in: PubMed
    Score: 0.525
  2. An immunohistochemical comparison of cytokeratin 7, cytokeratin 15, cytokeratin 19, CAM 5.2, carcinoembryonic antigen, and nestin in differentiating porocarcinoma from squamous cell carcinoma. Hum Pathol. 2012 Aug; 43(8):1265-72.
    View in: PubMed
    Score: 0.492
  3. Methodology matters, but…. J Cutan Pathol. 2012 Jan; 39(1):78-9; author reply 83-7.
    View in: PubMed
    Score: 0.474
  4. Expression of stem-cell markers (cytokeratin 15 and nestin) in primary adnexal neoplasms-clues to etiopathogenesis. Am J Dermatopathol. 2010 Dec; 32(8):774-9.
    View in: PubMed
    Score: 0.454
  5. D2-40 expression in primary scarring and nonscarring alopecia. Am J Dermatopathol. 2010 Jul; 32(5):427-31.
    View in: PubMed
    Score: 0.441
  6. The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin. Mod Pathol. 2010 May; 23(5):713-9.
    View in: PubMed
    Score: 0.431
  7. Microcystic adnexal carcinoma: an immunohistochemical reappraisal. Mod Pathol. 2008 Feb; 21(2):178-85.
    View in: PubMed
    Score: 0.369
  8. Tumoral PD-L1 expression in desmoplastic melanoma is associated with depth of invasion, tumor-infiltrating CD8 cytotoxic lymphocytes and the mixed cytomorphological variant. Mod Pathol. 2017 03; 30(3):357-369.
    View in: PubMed
    Score: 0.173
  9. Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome. J Am Acad Dermatol. 2016 Sep; 75(3):595-602.
    View in: PubMed
    Score: 0.169
  10. Frequency of telomerase reverse transcripter promoter mutations in desmoplastic melanoma subtypes: analyses of 76 cases. Melanoma Res. 2016 08; 26(4):361-6.
    View in: PubMed
    Score: 0.168
  11. Neurofibromin protein loss in desmoplastic melanoma subtypes: implicating NF1 allelic loss as a distinct genetic driver? Hum Pathol. 2016 07; 53:82-90.
    View in: PubMed
    Score: 0.163
  12. Neurotrophin receptors and perineural invasion in desmoplastic melanoma. J Am Acad Dermatol. 2015 May; 72(5):851-8.
    View in: PubMed
    Score: 0.152
  13. p40 exhibits better specificity than p63 in distinguishing primary skin adnexal carcinomas from cutaneous metastases. Hum Pathol. 2014 May; 45(5):1078-83.
    View in: PubMed
    Score: 0.141
  14. Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal. Mod Pathol. 2012 Apr; 25(4):505-15.
    View in: PubMed
    Score: 0.122
  15. Immunohistochemistry in the diagnosis of cutaneous neoplasms. Future Oncol. 2010 Jan; 6(1):93-109.
    View in: PubMed
    Score: 0.106
  16. Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans. Mod Pathol. 2008 Jan; 21(1):31-8.
    View in: PubMed
    Score: 0.091
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.